Keep Mango In Your Wallet & Your Portfolio
Our common stock ticker symbol is MGRX.
MGRX common shares are traded on the NASDAQ.
Go to the Stock Info page on this web tab, or you may visit www.Nasdaq.com or other financial portals or stock brokerage apps or websites.
MGRX successfully completed its Initial Public Offering on March 21, 2023.
We are on a calendar year that ends December 31.
You should contact Mangoceuticals, Inc.’s transfer agent, ClearTrust, LLC, at:
16540 Pointe Village Drive, Suite 210
Lutz, Florida, 33558
The CUSIP # for MGRX is 56270V 205
The date for the next Annual Shareholders Meeting has yet to be determined. We will announce it and make its materials available to shareholders through the relevant filing with the SEC.
Our website at www.MangoRx.com, along with our SEC filings which are provided on our website, are the most comprehensive sources. Also, see also our list of social media accounts, below.
Bios for our Management Team, Advisory Board and Board of Directors are listed on the Management page of this web tab.
Turner, Stone & Company, L.L.P.
12700 Park Central Drive, Suite 1400
Dallas, TX 75251
Tel: 972.239.1660
When we have job openings, we will usually post them on the major national online job websites.
The Company was incorporated in 2021 in the state of Texas.
Our offices are located at
15110 Dallas Parkway, Suite 600
Dallas, Texas 75248.
No.
No, as a developmental stage company, MGRX plans to reinvest cash flow back into the business for the foreseeable future.
Contact us at investors@mangorx.com.
© 2025 Mangoceuticals, Inc. All Rights Reserved.